Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Adicet Bio Inc (ACET)

Adicet Bio Inc (ACET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Adicet Bio Inc. is a biotechnology company. It engages in discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio Inc., formerly known as RESTORBIO INC, is based in Calif.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Sales 0 0 0 0 0
Sales Growth unch unch unch unch unch
Net Income -30,520 -26,860 -31,220 -28,210 -28,730
Net Income Growth -13.63% +13.97% -10.67% +1.81% +5.74%

Balance Sheet

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Total Assets 192,360 140,480 162,970 191,270 220,220
Total Assets Growth +36.93% -13.80% -14.80% -13.15% -10.47%
Total Liabilities 33,150 31,340 29,600 29,830 33,610
Total Liabilities Growth +5.78% +5.88% -0.77% -11.25% -2.38%

Cash Flow

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Operating Cash Flow -95,250 -74,340 -52,030 -25,400 -92,380
Operating Cash Flow Growth -28.13% -42.88% -104.84% +72.50% -35.30%
Net Cash Flow -17,610 -27,400 -21,780 -28,360 -100,310
Change in Net Cash Flow +35.73% -25.80% +23.20% +71.73% -84.97%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.